Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
2.
J Comp Pathol ; 150(2-3): 184-93, 2014.
Article in English | MEDLINE | ID: mdl-24225342

ABSTRACT

Canine mammary tumours (CMTs) are the most common tumours of entire female dogs and represent a promising model for human breast cancer. Little is known about the presence and prognostic value of lymphangiogenesis in CMTs. The aims of the present study were to analyze selected characteristics of lymphatic vessels in CMTs, to evaluate their prognostic significance and to compare these results with studies of human breast cancer. Fifty-six benign CMTs, 55 malignant CMTs and 13 control samples of normal canine mammary gland tissue were studied. Serial immunohistochemical labelling with the lymphatic marker prox-1 and the proliferation marker Ki67 was performed. In intratumoural (IT) and peritumoural (PT) regions, the lymphatic vessel density (LVD), mean lymphatic vessel perimeter (LVP) and relative area occupied by lymphatic vessels (LVA) were analyzed. Lymphatic endothelial cell proliferation (LECP) and tumour cell proliferation (TCP) were also measured. Lymphatic vessels were identified in IT and PT regions and lymphangiogenesis was present in both regions. The IT lymphatic vessels were smaller, less numerous and occupied a smaller relative area compared with those of the PT region. Although no differences in lymphatic vessel parameters were observed between benign and malignant tumours, control tissue differed significantly from neoplastic tissue. None of the lymphatic vessel parameters showed a prognostic value, except for LECP in PT regions of benign tumours. The findings were in accordance with results of investigations into human breast cancer, which supports the use of dogs with spontaneously occurring CMTs as an animal model in comparative oncology trials.


Subject(s)
Adenoma/veterinary , Carcinoma/veterinary , Dog Diseases/pathology , Lymphangiogenesis/physiology , Lymphatic Metastasis/pathology , Mammary Neoplasms, Animal/pathology , Adenoma/metabolism , Adenoma/pathology , Animals , Biomarkers, Tumor/metabolism , Carcinoma/metabolism , Carcinoma/pathology , Dog Diseases/metabolism , Dogs , Female , Homeodomain Proteins/metabolism , Mammary Neoplasms, Animal/metabolism , Prognosis , Tumor Suppressor Proteins/metabolism
3.
J Comp Pathol ; 150(2-3): 175-83, 2014.
Article in English | MEDLINE | ID: mdl-24231306

ABSTRACT

Angiogenesis in canine mammary tumours (CMTs) has been described previously; however, only the intratumoural (IT) region has been studied and information on peritumoural (PT) angiogenesis is lacking. In this study, the blood vessel density (BVD), blood vessel perimeter (BVP) and blood vessel area (BVA) in IT and PT regions of 56 benign CMTs, 55 malignant CMTs and 13 samples of normal mammary gland tissue were analyzed. In addition, the blood endothelial cell proliferation (BECP) as an indicator of ongoing angiogenesis was investigated. The prognostic value of each parameter was also examined. Blood vessels and proliferating blood endothelial cells were present in IT and PT regions of both benign and malignant tumours. The vessels in the PT region had a significantly higher area and perimeter compared with those in the IT region. Malignant tumours showed significantly more vessels with a smaller total BVA and a higher BECP compared with benign tumours and control tissue. In the PT regions there was a significantly higher BVD, BVA and BVP compared with the vessels in control tissue. Only the IT and PT BVD and PT BECP in benign tumours allowed prediction of survival. The morphology of blood vessels in CMTs shows similarities with those in human breast cancer, which strengthens the case for the use of dogs with CMTs in comparative oncology trials.


Subject(s)
Dog Diseases/pathology , Mammary Neoplasms, Animal/pathology , Neovascularization, Pathologic/veterinary , Animals , Dogs , Endothelial Cells/pathology , Female , Neovascularization, Pathologic/pathology , Prognosis
4.
J Comp Pathol ; 148(4): 307-17, 2013 May.
Article in English | MEDLINE | ID: mdl-23123127

ABSTRACT

Canine mammary tumours (CMTs) are the most common neoplasms in intact female dogs. Bitches with spontaneously arising CMTs represent a promising animal model for human breast cancer research. The aim of the present study was to develop an immunohistochemical protocol for the identification of blood and lymphatic vessels in CMTs. Antibodies specific for human lymphatic vessels (prox-1, lyve-1, podoplanin and D2-40) and blood vessels (von Willebrand factor [vWf], CD31 and CD34) were utilized. Serial sections of 18 samples (eight samples of normal canine mammary tissue, five benign and five malignant CMTs) were examined. Antibodies specific for podoplanin, D2-40 and CD34 showed no immunoreactivity with canine tissue. Prox-1 and CD31 were determined to be the most suitable markers for lymphatic and blood vessels, respectively.


Subject(s)
Blood Vessels/metabolism , Dog Diseases/metabolism , Lymphatic Vessels/metabolism , Mammary Glands, Animal/metabolism , Mammary Neoplasms, Animal/metabolism , Neovascularization, Pathologic/veterinary , Animals , Antibodies, Monoclonal, Murine-Derived/metabolism , Biomarkers/metabolism , Dog Diseases/pathology , Dogs , Female , Homeodomain Proteins/metabolism , Mammary Glands, Animal/pathology , Mammary Neoplasms, Animal/pathology , Membrane Glycoproteins/metabolism , Neovascularization, Pathologic/metabolism , Neovascularization, Pathologic/pathology , Tumor Suppressor Proteins/metabolism , Vesicular Transport Proteins/metabolism
5.
Reprod Domest Anim ; 46(6): 1112-31, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21645126

ABSTRACT

Canine mammary tumours (CMTs) are the most common neoplasms in intact female dogs. Although the prevalence of these tumours decreases in regions where preventive ovari(ohyster)ectomy is performed, it remains an important disease entity in veterinary medicine. Moreover, treatment options are limited in comparison with human breast cancer. Nevertheless, recent human treatment protocols might have potential in bitches suffering from CMTs.


Subject(s)
Dog Diseases/pathology , Mammary Neoplasms, Animal/pathology , Animals , Antineoplastic Agents/therapeutic use , Dog Diseases/epidemiology , Dog Diseases/therapy , Dogs , Female , Mammary Neoplasms, Animal/epidemiology , Mammary Neoplasms, Animal/therapy , Prevalence , Prognosis , Risk Factors
7.
Reprod Domest Anim ; 44(5): 751-6, 2009 Oct.
Article in English | MEDLINE | ID: mdl-18992091

ABSTRACT

Normal mammalian sex differentiation takes place in three genetically controlled steps: chromosomal sex determination (XX or XY), gonadal differentiation and development of the phenotypic sex. Animals are considered to be sex reversed if chromosomal sex determination and gonadal development are not in agreement. In this report, sex reversal is described in a 1.5-year-old Podenco dog that was referred because of suspected recurrent growth of a previously removed os clitoridis in the vulva. With that exception the dog was phenotypically female, but had never been in oestrus and exhibited male behaviour. Abdominal ultrasonography showed a small tubular structure dorsal to the bladder, consistent with a uterus. An ovoid structure resembling a gonad was visible between the right kidney and inguinal canal. Plasma testosterone concentrations before and after GnRH administration indicated the presence of functional testicular tissue. Two testes, each with its epididymis and ductus deferens, and a complete bicornuate uterus were removed surgically. Cytogenetic analysis of peripheral blood lymphocytes showed a normal female karyotype (78, XX). These findings are consistent with the diagnosis of an XX male. PCR analysis of genomic DNA revealed that the SRY gene was absent. In summary, this report describes the first SRY-negative XX male Podenco dog with an almost complete female phenotype despite high basal and stimulated plasma testosterone concentrations. It is hypothesized that the clinical observations in this dog may have been caused by reduced and delayed Müllerian-inhibiting substance secretion and the absence of conversion of testosterone to dihydrotestosterone due to 5alpha-reductase deficiency.


Subject(s)
Dogs/genetics , Sex Differentiation , Sex-Determining Region Y Protein/analysis , Animals , DNA/analysis , Disorders of Sex Development , Estradiol/blood , Female , Genitalia, Female/anatomy & histology , Genitalia, Female/diagnostic imaging , Gonadotropin-Releasing Hormone/administration & dosage , Luteinizing Hormone/blood , Male , Phenotype , Polymerase Chain Reaction , Sex Determination Processes , Sex Differentiation/genetics , Sex-Determining Region Y Protein/genetics , Testis/anatomy & histology , Testis/growth & development , Testosterone/blood , Ultrasonography
8.
Tijdschr Diergeneeskd ; 133(16): 654-61, 2008 Aug 15.
Article in English | MEDLINE | ID: mdl-18788186

ABSTRACT

Equine sarcoidosis is a rare disorder usually characterized by exfoliative dermatitis, moderate to severe wasting, and sarcoidal granulomatous inflammation of multiple organ systems. It has an unknown aetiopathogenesis. The condition is not related to equine sarcoid. This case report describes generalized cutaneous and systemic sarcoidosis in an 11-year-old Trakehner mare (case A) and in a 7-year-old Dutch Warmblood gelding (case B). Case A was presented with cutaneous sarcoidosis on the head and body and was diagnosed on the basis of histological examination of skin. Case B presented with multiple subcutaneous nodules (2-15 cm in diameter) and the diagnosis was established at postmortem examination. Both horses showed distinctive histology of the skin with extensive lymphohistiocytic infiltration and Langhans-type multinucleated giant cells. Haematology and biochemistry revealed a normal total white blood cell count with a right shift in both horses. Case B was anaemic and had a slightly elevated total protein concentration with hyperglobulinaemia. Both horses were unresponsive to corticosteroids and were euthanized.


Subject(s)
Giant Cells, Foreign-Body/pathology , Giant Cells, Langhans/pathology , Horse Diseases/diagnosis , Sarcoidosis/veterinary , Skin Diseases/veterinary , Animals , Fatal Outcome , Female , Horse Diseases/pathology , Horses , Immunohistochemistry/veterinary , Male , Sarcoidosis/diagnosis , Sarcoidosis/pathology , Skin/pathology , Skin Diseases/diagnosis , Skin Diseases/pathology
10.
Equine Vet J ; 36(1): 46-50, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14756371

ABSTRACT

REASONS FOR PERFORMING STUDY: To present the first report of a case series concerning equine idiopathic muscular hypertrophy of the oesophagus (IMHO). OBJECTIVES: To investigate the clinical and pathological features of the disorder. METHODS: The medical records of 31 horses suffering from the disorder were reviewed retrospectively. In all these animals the diagnosis was confirmed at post mortem examination. RESULTS: The median age of the affected horses was 12.5 +/- 5.6 years (range 1-26) without sex or breed predilection. Only 2 out of 31 horses showed clinical signs associated with oesophageal dysfunction, indicating that the muscular hypertrophy was rather a coincidental post mortem finding. Histology revealed thickening of the distal portion of the oesophagus mainly involving the circular layer of the tunica muscularis without fibrosis or inflammation. In 8 cases, the disorder was seen in concurrence with idiopathic hypertrophy of the tunica muscularis of various other parts of the gastrointestinal tract. CONCLUSIONS: In the majority of patients, IMHO was a coincidental finding at post mortem examination usually confined to the smooth, circular muscle layer of the tunica muscularis externa. POTENTIAL RELEVANCE: Further research is necessary to study the precise effect of IMHO on oesophageal function.


Subject(s)
Esophageal Diseases/veterinary , Esophagus/pathology , Horse Diseases/pathology , Muscle, Smooth/pathology , Animals , Esophageal Diseases/pathology , Female , Horses , Hypertrophy/pathology , Hypertrophy/veterinary , Male , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...